Inmune Bio, Inc. (INMB) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.86 | +11.8% |
| 2024 | $-2.11 | -26.3% |
| 2023 | $-1.67 | -9.9% |
| 2022 | $-1.52 | +19.1% |
| 2021 | $-1.88 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.86 | +11.8% |
| 2024 | $-2.11 | -26.3% |
| 2023 | $-1.67 | -9.9% |
| 2022 | $-1.52 | +19.1% |
| 2021 | $-1.88 | — |